{"id":"https://openalex.org/W2315769872","doi":"https://doi.org/10.2298/vsp141119047t","title":"Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad","display_name":"Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad","alternate_titles":[],"publication_year":2016,"publication_date":"2016-06-01","ids":{"openalex":"https://openalex.org/W2315769872","doi":"https://doi.org/10.2298/vsp141119047t","mag":"2315769872","pmid":"https://pubmed.ncbi.nlm.nih.gov/27498444"},"language":"en","primary_location":{"id":"doi:10.2298/vsp141119047t","doi":"https://doi.org/10.2298/vsp141119047t","is_oa":true,"landing_page_url":"https://doi.org/10.2298/vsp141119047t","pdf_url":"http://www.doiserbia.nb.rs/ft.aspx?id=0042-84501600047T","source":{"id":"https://openalex.org/S123141016","display_name":"Vojnosanitetski pregled","issn_l":"0042-8450","issn":["0042-8450","2406-0720"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321872","host_organization_name":"Military Health Department, Ministry of Defance, Serbia","host_organization_lineage":["https://openalex.org/P4310321872"],"host_organization_lineage_names":["Military Health Department, Ministry of Defance, Serbia"],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vojnosanitetski pregled","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2315769872"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.doiserbia.nb.rs/ft.aspx?id=0042-84501600047T","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068165791","display_name":"Ana Tom\u00e1s","orcid":"https://orcid.org/0000-0003-2361-872X","observed_orcids":["https://orcid.org/0000-0003-2361-872X"]},"institutions":[{"id":"https://openalex.org/I170726198","display_name":"University of Novi Sad","ror":"https://ror.org/00xa57a59","country_code":"RS","type":"education","lineage":["https://openalex.org/I170726198"]}],"countries":["RS"],"is_corresponding":true,"raw_author_name":"Ana Tomas","raw_affiliation_strings":["Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","institution_ids":["https://openalex.org/I170726198"]},{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;","institution_ids":["https://openalex.org/I170726198"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008937907","display_name":"Z. Tomi\u0107","orcid":"https://orcid.org/0000-0002-1838-7376","observed_orcids":["https://orcid.org/0000-0002-1838-7376"]},"institutions":[{"id":"https://openalex.org/I170726198","display_name":"University of Novi Sad","ror":"https://ror.org/00xa57a59","country_code":"RS","type":"education","lineage":["https://openalex.org/I170726198"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Zdenko Tomic","raw_affiliation_strings":["Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","institution_ids":["https://openalex.org/I170726198"]},{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;","institution_ids":["https://openalex.org/I170726198"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080573143","display_name":"Boris Milija\u0161evi\u0107","orcid":"https://orcid.org/0000-0003-4555-8801","observed_orcids":["https://orcid.org/0000-0003-4555-8801"]},"institutions":[{"id":"https://openalex.org/I170726198","display_name":"University of Novi Sad","ror":"https://ror.org/00xa57a59","country_code":"RS","type":"education","lineage":["https://openalex.org/I170726198"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Boris Milijasevic","raw_affiliation_strings":["Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;","Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","institution_ids":["https://openalex.org/I170726198"]},{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;","institution_ids":["https://openalex.org/I170726198"]},{"raw_affiliation_string":"Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia","institution_ids":["https://openalex.org/I170726198"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109473007","display_name":"Milica Ban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170726198","display_name":"University of Novi Sad","ror":"https://ror.org/00xa57a59","country_code":"RS","type":"education","lineage":["https://openalex.org/I170726198"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Milica Ban","raw_affiliation_strings":["Faculty of Medicine, Novi Sad"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Novi Sad","institution_ids":["https://openalex.org/I170726198"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069102109","display_name":"Olga Horvat","orcid":"https://orcid.org/0000-0001-9740-9862","observed_orcids":["https://orcid.org/0000-0001-9740-9862"]},"institutions":[{"id":"https://openalex.org/I170726198","display_name":"University of Novi Sad","ror":"https://ror.org/00xa57a59","country_code":"RS","type":"education","lineage":["https://openalex.org/I170726198"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Olga Horvat","raw_affiliation_strings":["Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","institution_ids":["https://openalex.org/I170726198"]},{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;","institution_ids":["https://openalex.org/I170726198"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065732307","display_name":"Sa\u0161a Vukmirovi\u0107","orcid":"https://orcid.org/0000-0002-3271-4492","observed_orcids":["https://orcid.org/0000-0002-3271-4492"]},"institutions":[{"id":"https://openalex.org/I170726198","display_name":"University of Novi Sad","ror":"https://ror.org/00xa57a59","country_code":"RS","type":"education","lineage":["https://openalex.org/I170726198"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Sasa Vukmirovic","raw_affiliation_strings":["Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","institution_ids":["https://openalex.org/I170726198"]},{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;","institution_ids":["https://openalex.org/I170726198"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023931793","display_name":"Ana Sabo","orcid":"https://orcid.org/0000-0002-2858-6723","observed_orcids":["https://orcid.org/0000-0002-2858-6723"]},"institutions":[{"id":"https://openalex.org/I170726198","display_name":"University of Novi Sad","ror":"https://ror.org/00xa57a59","country_code":"RS","type":"education","lineage":["https://openalex.org/I170726198"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"Ana Sabo","raw_affiliation_strings":["Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;"],"raw_orcid":"https://orcid.org/0000-0002-2858-6723","affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad","institution_ids":["https://openalex.org/I170726198"]},{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia;","institution_ids":["https://openalex.org/I170726198"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068165791"],"corresponding_institution_ids":["https://openalex.org/I170726198"],"apc_list":{"value":150,"currency":"EUR","value_usd":161},"apc_paid":{"value":150,"currency":"EUR","value_usd":161},"fwci":0.2134,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.55517175,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"73","issue":"6","first_page":"531","last_page":"537"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.020899999886751175,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12664","display_name":"Clinical practice guidelines implementation","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.9259999990463257},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7409999966621399},{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.6919999718666077},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.5849999785423279},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.6259999871253967},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.7649999856948853},{"id":"https://openalex.org/keywords/thiazide-diuretics","display_name":"thiazide diuretics","score":0.9800000190734863},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.8960000276565552},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9829999804496765},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.6650000214576721},{"id":"https://openalex.org/keywords/pharmaceutical-expenditure","display_name":"pharmaceutical expenditure","score":0.45399999618530273},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6679999828338623},{"id":"https://openalex.org/keywords/novi-sad","display_name":"Novi Sad","score":0.9459999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8658744692802429},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.7566140294075012},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.7074156999588013},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6688640117645264},{"id":"https://openalex.org/C2780192228","wikidata":"https://www.wikidata.org/wiki/Q575890","display_name":"Antihypertensive drug","level":3,"score":0.647930920124054},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5357453227043152},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4648984968662262},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45521682500839233},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.4329182207584381},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.38741394877433777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37226539850234985},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29141315817832947},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.2651211619377136},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.10172757506370544}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017723","descriptor_name":"Drug Utilization Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019983","descriptor_name":"Guideline Adherence","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D055771","descriptor_name":"Serbia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.2298/vsp141119047t","doi":"https://doi.org/10.2298/vsp141119047t","is_oa":true,"landing_page_url":"https://doi.org/10.2298/vsp141119047t","pdf_url":"http://www.doiserbia.nb.rs/ft.aspx?id=0042-84501600047T","source":{"id":"https://openalex.org/S123141016","display_name":"Vojnosanitetski pregled","issn_l":"0042-8450","issn":["0042-8450","2406-0720"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321872","host_organization_name":"Military Health Department, Ministry of Defance, Serbia","host_organization_lineage":["https://openalex.org/P4310321872"],"host_organization_lineage_names":["Military Health Department, Ministry of Defance, Serbia"],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vojnosanitetski pregled","raw_type":"journal-article"},{"id":"pmid:27498444","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27498444","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vojnosanitetski pregled","raw_type":"Journal Article"},{"id":"pmh:oai:scindeks:0042-84501606531T","doi":null,"is_oa":true,"landing_page_url":"http://scindeks.ceon.rs/article.aspx?artid=0042-84501606531T","pdf_url":null,"source":{"id":"https://openalex.org/S4377196112","display_name":"SCIndeks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vojnosanitetski pregled (2016) 73(6):531-537","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:9b3e5e97439845108a5652f8f2be9260","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9b3e5e97439845108a5652f8f2be9260","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vojnosanitetski Pregled, Vol 73, Iss 6, Pp 531-537 (2016)","raw_type":"article"},{"id":"mag:2741236671","doi":null,"is_oa":false,"landing_page_url":"http://www.doiserbia.nb.rs/ft.aspx?id=0042-84501600047T","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.2298/vsp141119047t","doi":"https://doi.org/10.2298/vsp141119047t","is_oa":true,"landing_page_url":"https://doi.org/10.2298/vsp141119047t","pdf_url":"http://www.doiserbia.nb.rs/ft.aspx?id=0042-84501600047T","source":{"id":"https://openalex.org/S123141016","display_name":"Vojnosanitetski pregled","issn_l":"0042-8450","issn":["0042-8450","2406-0720"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310321872","host_organization_name":"Military Health Department, Ministry of Defance, Serbia","host_organization_lineage":["https://openalex.org/P4310321872"],"host_organization_lineage_names":["Military Health Department, Ministry of Defance, Serbia"],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vojnosanitetski pregled","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G1330770582","display_name":null,"funder_award_id":"41012","funder_id":"https://openalex.org/F4320322729","funder_display_name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja"},{"id":"https://openalex.org/G5742332245","display_name":null,"funder_award_id":"III41012","funder_id":"https://openalex.org/F4320322729","funder_display_name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja"}],"funders":[{"id":"https://openalex.org/F4320322729","display_name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","ror":"https://ror.org/01znas443"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2315769872.pdf","grobid_xml":"https://content.openalex.org/works/W2315769872.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W2330957","https://openalex.org/W12496815","https://openalex.org/W184815967","https://openalex.org/W1961941199","https://openalex.org/W1990908213","https://openalex.org/W2009165423","https://openalex.org/W2010865202","https://openalex.org/W2047220243","https://openalex.org/W2071086392","https://openalex.org/W2075450740","https://openalex.org/W2077876221","https://openalex.org/W2083928661","https://openalex.org/W2086659372","https://openalex.org/W2087655403","https://openalex.org/W2092798752","https://openalex.org/W2096431191","https://openalex.org/W2100092136","https://openalex.org/W2121875558","https://openalex.org/W2133416234","https://openalex.org/W2151067773","https://openalex.org/W2154835844","https://openalex.org/W2156121263","https://openalex.org/W2334143697","https://openalex.org/W2560462607","https://openalex.org/W2584590088","https://openalex.org/W6988133097"],"related_works":["https://openalex.org/W2151067773","https://openalex.org/W4282921299","https://openalex.org/W2093997951","https://openalex.org/W2305421582","https://openalex.org/W2142461254","https://openalex.org/W1973004203","https://openalex.org/W617972029","https://openalex.org/W2162776524","https://openalex.org/W2037272059"],"abstract_inverted_index":{"BACKGROUND/AIM:":[0],"Hypertension":[1],"is":[2,309,312],"one":[3],"of":[4,8,18,35,52,67,84,92,99,109,140,152,194,206,217,221,238,245,257,270,277,284,287,296,305,326],"the":[5,41,50,57,64,90,107,127,150,204,224,233,243,264,268,324],"leading":[6],"causes":[7],"cardiovascular":[9],"morbidity":[10],"and":[11,13,62,96,175,186,196,210,215,299,303],"mortality":[12],"more":[14,180,189,258],"than":[15,182,190],"a":[16,82,146,313],"half":[17],"all":[19,116,203,239,267],"health":[20],"insurance":[21],"expenditures":[22],"for":[23,315],"reimbursed":[24],"medicines":[25],"are":[26],"allocated":[27],"to":[28,39,59,320],"antihypertensive":[29,42,240,288],"drugs":[30,241,269],"in":[31,49,78,104,119,149,219,223,242,250,275,282,292],"Serbia.":[32],"The":[33,87,192,255],"aim":[34],"this":[36,271,293],"study":[37,75],"was":[38,76,113,124,156,200,229,261],"identify":[40],"drug":[43],"utilization":[44,283],"patterns":[45],"among":[46],"hypertensive":[47],"outpatients":[48,105],"city":[51,151,244],"Novi":[53,79,120,153,246],"Sad,":[54],"Serbia,":[55],"determine":[56],"adherence":[58],"clinical":[60],"guidelines":[61,212,265],"address":[63],"economic":[65],"aspects":[66],"current":[68],"prescribing":[69],"practices.":[70],"METHODS:":[71],"This":[72],"retrospective":[73],"observational":[74],"conducted":[77],"Sad":[80,247],"over":[81,145,236],"period":[83,148],"six":[85],"months.":[86],"data":[88],"on":[89,102,143],"number":[91],"packages,":[93],"size":[94],"their,":[95],"retail":[97],"price":[98],"antihypertensives":[100,141],"issued":[101,142],"prescription":[103,144],"with":[106,318],"diagnosis":[108],"essential":[110],"arterial":[111],"hypertension":[112,222],"collected":[114],"from":[115],"state-owned":[117],"pharmacies":[118],"Sad.":[121],"Drug":[122],"consumption":[123,139,193,228],"analyzed":[125],"using":[126],"Anatomical":[128],"Therapeutic":[129],"Chemical":[130],"(ATC)/":[131],"defined":[132],"daily":[133],"dose":[134],"(DDD)":[135],"methodology.":[136],"RESULTS:":[137],"Total":[138],"6-month":[147],"sad,":[154],"Serbia":[155],"283.48":[157],"DDD":[158],"per":[159,162],"1,000":[160],"inhabitans":[161],"day":[163],"(DID).":[164],"Angiotensin":[165],"converting":[166],"enzyme":[167],"inhibitors":[168,308],"(ACEi)":[169],"were":[170,176,248,290],"most":[171],"commonly":[172],"prescribed":[173],"drugs,":[174],"used":[177],"3":[178],"times":[179,188],"often":[181],"calcium":[183],"channel":[184],"blockers":[185],"5":[187],"beta-blockers.":[191],"diuretics":[195,218,302],"angiotensin":[197],"receptor":[198],"antagonists":[199],"low":[201,231],"within":[202],"groups":[205,286],"outpatients.":[207],"Both":[208],"national":[209],"international":[211],"state":[213],"superiority":[214],"effectiveness":[216],"treatment":[220,276],"elderly,":[225],"but":[226],"their":[227],"unreasonable":[230],"despite":[232,263],"fact":[234],"that":[235],"70%":[237],"dispensed":[249],"people":[251],"aged":[252],">":[253],"60.":[254],"use":[256],"expensive":[259,306],"ACEi":[260],"observed":[262],"deeming":[266],"class":[272],"equally":[273],"effective":[274],"hypertension.":[278],"CONCLUSION:":[279],"Large":[280],"differences":[281],"different":[285],"agents":[289],"noted":[291],"study.":[294],"Underutilization":[295],"valuable,":[297],"efficacious,":[298],"cost-effective":[300],"thiazide":[301],"overuse":[304],"ACE":[307],"unjustifiable.":[310],"There":[311],"potential":[314],"large":[316],"savings":[317],"switching":[319],"low-price":[321],"ACEi,":[322],"modeling":[323],"practice":[325],"Scandinavian":[327],"countries.":[328]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2315769872","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
